Retrospective analysis of the international standard-dose FOLFIRI (plus bevacizumab) regimen in Japanese patients with unresectable advanced or recurrent colorectal carcinoma
Tomohiro Nishi, Yasuo Hamamoto, Etsuko Warita, Junko Miyamoto, Noriyuki Akutsu, Yasuhiro Yamanaka, Michitaka Nagase, Hirofumi FujiiVolume:
16
Language:
english
Pages:
6
DOI:
10.1007/s10147-011-0213-7
Date:
October, 2011
File:
PDF, 1.57 MB
english, 2011